Preparing for a new era in chronic cough management

Area of Science:

• Pulmonology
• Internal Medicine
• Pharmacology

Background:

• Chronic cough affects millions annually, causing substantial patient burden and high healthcare expenditures.
• Current management strategies for chronic cough are varied, with inconsistent treatment guidelines and no specific FDA-approved agents.
• Factors contributing to costs include repeated testing, polypharmacy, and comorbidities from inadequate treatment.

Purpose of the Study:

• To review the current landscape of chronic cough management.
• To highlight the impact of chronic cough on patients and healthcare systems.
• To discuss emerging therapies and the importance of evidence-based, cost-effective treatment approaches.

Main Methods:

• Literature review of current chronic cough guidelines and treatment options.
• Analysis of factors contributing to the economic burden of chronic cough.
• Examination of pharmacologic and non-pharmacologic therapeutic modalities.

Main Results:

• Chronic cough is a significant clinical challenge with a considerable impact on quality of life.
• Existing treatment guidelines lack uniformity, and current therapies are often off-label.
• New targeted treatments are in development, offering potential for improved patient outcomes.

Conclusions:

• A streamlined, evidence-based approach integrating guidelines, patient factors, and novel therapies is needed for optimal chronic cough management.
• Managed care organizations should prioritize cost-effective strategies for chronic cough.
• Future directions include the development and implementation of targeted therapies for chronic cough.